ICU Operating Margin from 2010 to 2026
| ICUI Stock | USD 150.03 0.75 0.50% |
Check ICU Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICU Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.7 M, Interest Expense of 128.6 M or Total Revenue of 2.9 B, as well as many indicators such as Price To Sales Ratio of 1.74, Dividend Yield of 0.0 or PTB Ratio of 3.58. ICU financial statements analysis is a perfect complement when working with ICU Medical Valuation or Volatility modules.
ICU | Operating Margin | Build AI portfolio with ICU Stock |
The Operating Margin trend for ICU Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether ICU Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest ICU Medical's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of ICU Medical over the last few years. It is ICU Medical's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.05 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
ICU Operating Margin Regression Statistics
| Arithmetic Mean | 0.12 | |
| Geometric Mean | 0.06 | |
| Coefficient Of Variation | 118.02 | |
| Mean Deviation | 0.1 | |
| Median | 0.08 | |
| Standard Deviation | 0.14 | |
| Sample Variance | 0.02 | |
| Range | 0.5521 | |
| R-Value | (0.76) | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.58 | |
| Significance | 0.0004 | |
| Slope | (0.02) | |
| Total Sum of Squares | 0.30 |
ICU Operating Margin History
About ICU Medical Financial Statements
Investors use fundamental indicators, such as ICU Medical's Operating Margin, to determine how well the company is positioned to perform in the future. Although ICU Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California. I C operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 15300 people.
Currently Active Assets on Macroaxis
When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:Check out the analysis of ICU Medical Correlation against competitors. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is there potential for Health Care Equipment & Supplies market expansion? Will ICU introduce new products? Factors like these will boost the valuation of ICU Medical. Market participants price ICU higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (0.32) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets |
ICU Medical's market price often diverges from its book value, the accounting figure shown on ICU's balance sheet. Smart investors calculate ICU Medical's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since ICU Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.